Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance
- PMID: 32021444
- PMCID: PMC6970243
- DOI: 10.2147/CMAR.S232994
Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance
Abstract
Background: Cervical cancer is the second most common female malignancies. But the exact etiology of cervical cancer is still under investigation. Recent observations revealed that the loss expression of Siva 1 was related to several different types of tumors. It could play an indispensable role in both exogenous and endogenous apoptotic signaling pathways. Nevertheless, the relationship between Siva 1 expression and cervical cancer progression has not yet been fully clarified. This study aimed to explore the functional role of Siva1 in cervical cancer.
Materials and methods: In this present experiment, expression of Siva 1 was detected in 87 cervical cancer, 34 CIN and 20 normal samples by immunohistochemistry. The correlation of Siva 1 expression and overall survival times (OS) was analyzed by Kaplan-Meier analysis. We up-regulated the expression of Siva 1 by plasmid pCMV3-Siva 1 in C33A cells. CCK8, flow cytometry, wound-healing, and transwell assays were performed to examine the influences of Siva 1 expression on cell proliferation, apoptosis, migration and invasion.
Results: The expression of Siva 1 was decreased in cervical cancer tissues compared with CIN and normal tissues. In addition, the Siva 1 immunoreactivity was significantly associated with tumor differentiation. Patients with Siva 1 negative staining exhibited a significantly decreased overall survival. Then, we established stable Siva 1 ectopic expression cells, and we found that elevated expression of Siva 1 promoted apoptosis, inhibited proliferation, and suppressed migration and invasion of cervical cancer cells.
Conclusion: The present study revealed a crucial role of Siva 1 in tumor progression and it may be a valuable prognostic indicator of cervical cancer.
Keywords: Siva 1; apoptosis; cervical cancer; prognosis; proliferation.
© 2020 Liu et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures





Similar articles
-
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1.Oncol Res. 2023 Feb 9;30(6):277-288. doi: 10.32604/or.2022.027301. eCollection 2022. Oncol Res. 2023. PMID: 37303491 Free PMC article.
-
Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.Oncol Lett. 2017 Aug;14(2):1512-1518. doi: 10.3892/ol.2017.6307. Epub 2017 Jun 2. Oncol Lett. 2017. PMID: 28789373 Free PMC article.
-
Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway.Mol Med Rep. 2020 Aug;22(2):1558-1566. doi: 10.3892/mmr.2020.11211. Epub 2020 Jun 3. Mol Med Rep. 2020. PMID: 32626967 Free PMC article.
-
Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.Drug Des Devel Ther. 2019 Apr 23;13:1289-1300. doi: 10.2147/DDDT.S200610. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31118568 Free PMC article.
-
Exploring the dual role of SIVA1 in cancer biology.Gene. 2025 May 20;950:149365. doi: 10.1016/j.gene.2025.149365. Epub 2025 Feb 28. Gene. 2025. PMID: 40024298 Review.
Cited by
-
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37256211 Free PMC article. Review.
-
A Personalized Genomics Approach of the Prostate Cancer.Cells. 2021 Jun 30;10(7):1644. doi: 10.3390/cells10071644. Cells. 2021. PMID: 34209090 Free PMC article.
-
Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.PLoS One. 2024 May 9;19(5):e0302856. doi: 10.1371/journal.pone.0302856. eCollection 2024. PLoS One. 2024. PMID: 38722955 Free PMC article.
-
FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function.Front Cell Dev Biol. 2022 Jan 10;9:826037. doi: 10.3389/fcell.2021.826037. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35083225 Free PMC article. Review.
-
SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth in vivo.J Cancer. 2024 Jun 11;15(13):4301-4312. doi: 10.7150/jca.92963. eCollection 2024. J Cancer. 2024. PMID: 38947376 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
LinkOut - more resources
Full Text Sources